Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone effect on post-CABG inflammatory mediators
IRCT201010022622N2Phase 2Completed
- Sponsor
- Tehran Heart Center
- Start
- Nov 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of prednisolone in coronary arteriosclerosis, sponsored by Tehran Heart Center. Primary endpoint: Change in inflammatory mediators after CABG surgery. Started Nov 2010; status: completed.
02
Drugs
prednisolone
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT201010022622N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201010022622N2.